NEOS Investment Management LLC Purchases Shares of 100,936 Astera Labs, Inc. $ALAB

NEOS Investment Management LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALABFree Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 100,936 shares of the company’s stock, valued at approximately $48,754,000. NEOS Investment Management LLC owned 0.06% of Astera Labs as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in ALAB. Keating Financial Advisory Services Inc. purchased a new position in shares of Astera Labs during the 2nd quarter worth approximately $25,000. Archer Investment Corp purchased a new stake in Astera Labs in the second quarter valued at approximately $30,000. Transamerica Financial Advisors LLC acquired a new position in Astera Labs during the second quarter worth $35,000. Continuum Advisory LLC acquired a new position in Astera Labs during the second quarter worth $37,000. Finally, Johnson Financial Group Inc. purchased a new position in shares of Astera Labs during the second quarter worth $43,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Demand for Astera Labs’ Scorpio, Aries and Taurus connectivity platforms is supporting expectations for robust third-quarter growth and reinforcing the company’s AI data-center expansion story. ALAB Stock Down 24% in a Month: Should Investors Buy the Dip or Wait?
  • Positive Sentiment: Astera’s role in supplying high-speed connectivity for large-scale AI data centers remains a key investment attraction, although NVIDIA retains a broader competitive advantage through its chips and software ecosystem. Better Artificial Intelligence Stock: Astera Labs vs. NVIDIA
  • Neutral Sentiment: The stock remains under pressure following its latest earnings report, declining 13.9% since results were released and 24% over the past month. The decline highlights elevated expectations and uncertainty about the next phase of growth. Why Is Astera Labs, Inc. (ALAB) Down 13.9% Since Last Earnings Report?
  • Negative Sentiment: Director Manuel Alba sold 183,000 shares for approximately $51.3 million, reducing his position by 41.9%. Director Stefan Dyckerhoff also sold a combined 12,499 shares worth about $3.4 million. Both transactions were conducted under pre-arranged Rule 10b5-1 trading plans, which may lessen their signal as discretionary insider bearishness but could still weigh on sentiment and add selling supply. SEC Form 4 Filing

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Citigroup reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. UBS Group reaffirmed a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Stifel Nicolaus boosted their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Jefferies Financial Group increased their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Finally, TD Cowen dropped their price objective on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $348.33.

Check Out Our Latest Report on Astera Labs

Astera Labs Stock Up 3.2%

Shares of ALAB opened at $282.82 on Friday. The company has a market capitalization of $49.07 billion, a price-to-earnings ratio of 140.01 and a beta of 3.77. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The stock has a 50 day moving average price of $332.37 and a 200 day moving average price of $253.97.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same quarter last year, the company earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Activity

In related news, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the company’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares of the company’s stock, valued at $32,872,551. This represents a 6.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 592,244 shares of company stock worth $209,729,973 over the last three months. Company insiders own 10.40% of the company’s stock.

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.